| 000 | 01827 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517144718.0 | ||
| 264 | 0 | _c20170905 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2017.03.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Tao | |
| 245 | 0 | 0 |
_aNeuroprotective and axonal outgrowth-promoting effects of tetramethylpyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxia. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c05 2017 |
||
| 300 |
_a137-147 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAxons _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCell Hypoxia _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEmbryo, Mammalian |
| 650 | 0 | 4 |
_aGlucose _xdeficiency |
| 650 | 0 | 4 |
_aHippocampus _xcytology |
| 650 | 0 | 4 |
_aHypoxia-Ischemia, Brain _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRecognition, Psychology _xdrug effects |
| 700 | 1 | _aGu, Jianbo | |
| 700 | 1 | _aWu, Liangmiao | |
| 700 | 1 | _aLi, Ning | |
| 700 | 1 | _aSun, Yewei | |
| 700 | 1 | _aYu, Pei | |
| 700 | 1 | _aWang, Yuqiang | |
| 700 | 1 | _aZhang, Gaoxiao | |
| 700 | 1 | _aZhang, Zaijun | |
| 773 | 0 |
_tNeuropharmacology _gvol. 118 _gp. 137-147 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2017.03.022 _zAvailable from publisher's website |
| 999 |
_c27015942 _d27015942 |
||